◼ Archived
Business
We're raising our price target on Eli Lilly as the obesity-drug boom rolls on
Eli Lilly stock reaches an all-time high amid surging GLP-1 sales and a heightened price target.
Fierce Pharma
7 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Business
US Treasury proposes a rule to crack down on high-tech investments in China, other adversaries
The United States Treasury proposes new rules adding biotechnology to its outbound investment security program to target China.
◼ Archived
Business
Pharma's new top lobbyist is a former House majority leader
Eric Cantor, the former House majority leader, has been selected as the new president and chief executive officer of PhRMA.
◼ Archived
Business
Eli Lilly CEO reveals astonishing shift in GLP-1 pill market
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✗
Novartis shareholder calls for board overhaul following costly deal setbacks: Reuters
A major Novartis shareholder is demanding a board overhaul following a series of costly drug trial setbacks and strategic failures.
◼ Archived
Business
🔮 fades ✗
AstraZeneca Shares Fall on Deal Talks With Bristol-Myers
AstraZeneca shares have declined following reports of potential $400 billion merger talks with Bristol Myers Squibb.
◼ Archived
Business
🔮 fades ✓
Johnson & Johnson proposes $5.5 billion talc settlement to end marathon legal fight
Johnson & Johnson proposes a $5.5 billion settlement to potentially resolve marathon talc litigation.